483
Medtronic NeuromodulationMedtronic Neuromodulation – FDA 483, Apr 3, 2013
Record Details
Medtronic Neuromodulation in Minneapolis, MN, was cited for significant quality system deficiencies during an FDA inspection. The firm distributed nonconforming medical devices, including SC catheters and DBS lead kits, which resulted in serious adverse events and numerous complaints. Additionally, the inspection revealed inadequate corrective and preventive action procedures, failures in design verification, and insufficient design change controls.
View Company Profile
ID · 1d2f7c9a-e15f-44d4-9605-f8d0800c7f03
Other documents for Medtronic Neuromodulation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.